Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label Extension (OLE) Study to Assess the Long-term Safety and Efficacy of AMG 334

NCT02174861 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT02174861
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02174861 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label Extension (OLE) Study to Assess the Long-term Safety and Efficacy of AMG 334
Lead sponsor
Amgen
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2014
Completion date
May 26, 2017
Enrollment
609 (actual)
Sites
65

Conditions

As the registry lists them; a condition with its own page is linked.

treatment for prevention of chronic migraine